NFL Biosciences S.A.
PAR: ALNFL.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bruno Lafont
- Employees
- 4
- Headquarters
- Castelnau-le-Lez, France
- IPO year
- 2021
- Market cap
- €12.2M
- Website
- https://www.nflbiosciences.com
Loading ALNFL…
Loading profile data…Frequently asked questions about ALNFL
What does NFL Biosciences S.A. (ALNFL.PA) do?
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and...
Where does ALNFL.PA trade?
NFL Biosciences S.A. (ALNFL.PA) trades on the Euronext Paris.
What sector is ALNFL.PA in?
NFL Biosciences S.A. (ALNFL.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NFL Biosciences S.A.?
Bruno Lafont is the chief executive officer of NFL Biosciences S.A. (ALNFL.PA).
Where is NFL Biosciences S.A. headquartered?
NFL Biosciences S.A. is headquartered in France.
Does ALNFL.PA pay a dividend?
NFL Biosciences S.A. (ALNFL.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALNFL.PA go public?
NFL Biosciences S.A. (ALNFL.PA) completed its initial public offering in 2021.